Amendment requires the Director of the Office of National Drug Control Policy to request the Institute of Medicine of the National Academy of Sciences to conduct a study to examine certain aspects of iatrogenic addiction, which is associated with prescription drugs like OxyContin.

Ask AI
Amendment Number
696
Description
Amendment requires the Director of the Office of National Drug Control Policy to request the Institute of Medicine of the National Academy of Sciences to conduct a study to examine certain aspects of iatrogenic addiction, which is associated with prescription drugs like OxyContin.
Purpose
An amendment numbered 11 printed in House Report 109-387 to direct the ONDCP to request the Institute of Medicine of the National Academy of Sciences to enter into an agreement under which the Institute agrees to conduct a study on iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets and directs the ONDCP to report to Congress on the study.
Congress
109
Type
HAMDT
Latest Action Date
Mar 9, 2006
Latest Action Text
On agreeing to the Lynch amendment (A011) Agreed to by voice vote.
Latest Action Time
14:02:45
Submitted Date
Mar 9, 2006
Chamber
House of Representatives
Update Date
Feb 3, 2022
Amendment 696 — Informed